Cargando…

A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family

BACKGROUND: To investigate the genetic causes and clinical characteristics of dominant optic atrophy (DOA) in a Chinese family. METHODS: A 5-generation pedigree of 35 family members including 12 individuals affected with DOA was recruited from Shenzhen Eye Hospital, China. Four affected family membe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Shaoyi, Huang, Xiaosheng, Cheng, Lin, Peng, Shiming, Zhu, Tianhui, Chen, Liang, Wang, Yan, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875404/
https://www.ncbi.nlm.nih.gov/pubmed/31781369
http://dx.doi.org/10.1155/2019/1424928
_version_ 1783473023633850368
author Mei, Shaoyi
Huang, Xiaosheng
Cheng, Lin
Peng, Shiming
Zhu, Tianhui
Chen, Liang
Wang, Yan
Zhao, Jun
author_facet Mei, Shaoyi
Huang, Xiaosheng
Cheng, Lin
Peng, Shiming
Zhu, Tianhui
Chen, Liang
Wang, Yan
Zhao, Jun
author_sort Mei, Shaoyi
collection PubMed
description BACKGROUND: To investigate the genetic causes and clinical characteristics of dominant optic atrophy (DOA) in a Chinese family. METHODS: A 5-generation pedigree of 35 family members including 12 individuals affected with DOA was recruited from Shenzhen Eye Hospital, China. Four affected family members and one unaffected family member were selected for whole exome sequencing. Sanger sequencing was used to confirm and screen the identified mutation in 18 members of the family. The disease-causing mutation was identified by bioinformatics analysis and confirmed by segregation analysis. The clinical characteristics of the family members were analyzed. RESULTS: A heterozygous missense mutation (c.1313A>G, p.D438G) in optic atrophy 1 (OPA1) was identified in 10 individuals affected with DOA in this family. None of the unaffected family members had the mutation. Patients in this family had vision loss since they were children or adolescence. The visual acuity decreased progressively to hand movement, except for one patient (IV-12) who had relatively good vision of 20/30 and 20/28. The fundus typically manifested as optic disc pallor. The visual fields, optical coherence tomography, and visual evoked potential suggested variable degree of abnormality in patients. Patients who had a history of cigarette smoking and alcohol drinking had more severe clinical manifestations. CONCLUSIONS: Our results suggest that the p.D438G mutation in OPA1 causes optic atrophy in this family. The patients who carried the mutation demonstrated heterogeneous clinical manifestations in this family. This is the first report on the c.1313A>G (p.D438G) mutation of OPA1 in a Chinese family affected with DOA.
format Online
Article
Text
id pubmed-6875404
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-68754042019-11-28 A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family Mei, Shaoyi Huang, Xiaosheng Cheng, Lin Peng, Shiming Zhu, Tianhui Chen, Liang Wang, Yan Zhao, Jun J Ophthalmol Research Article BACKGROUND: To investigate the genetic causes and clinical characteristics of dominant optic atrophy (DOA) in a Chinese family. METHODS: A 5-generation pedigree of 35 family members including 12 individuals affected with DOA was recruited from Shenzhen Eye Hospital, China. Four affected family members and one unaffected family member were selected for whole exome sequencing. Sanger sequencing was used to confirm and screen the identified mutation in 18 members of the family. The disease-causing mutation was identified by bioinformatics analysis and confirmed by segregation analysis. The clinical characteristics of the family members were analyzed. RESULTS: A heterozygous missense mutation (c.1313A>G, p.D438G) in optic atrophy 1 (OPA1) was identified in 10 individuals affected with DOA in this family. None of the unaffected family members had the mutation. Patients in this family had vision loss since they were children or adolescence. The visual acuity decreased progressively to hand movement, except for one patient (IV-12) who had relatively good vision of 20/30 and 20/28. The fundus typically manifested as optic disc pallor. The visual fields, optical coherence tomography, and visual evoked potential suggested variable degree of abnormality in patients. Patients who had a history of cigarette smoking and alcohol drinking had more severe clinical manifestations. CONCLUSIONS: Our results suggest that the p.D438G mutation in OPA1 causes optic atrophy in this family. The patients who carried the mutation demonstrated heterogeneous clinical manifestations in this family. This is the first report on the c.1313A>G (p.D438G) mutation of OPA1 in a Chinese family affected with DOA. Hindawi 2019-11-03 /pmc/articles/PMC6875404/ /pubmed/31781369 http://dx.doi.org/10.1155/2019/1424928 Text en Copyright © 2019 Shaoyi Mei et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mei, Shaoyi
Huang, Xiaosheng
Cheng, Lin
Peng, Shiming
Zhu, Tianhui
Chen, Liang
Wang, Yan
Zhao, Jun
A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
title A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
title_full A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
title_fullStr A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
title_full_unstemmed A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
title_short A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family
title_sort missense mutation in opa1 causes dominant optic atrophy in a chinese family
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875404/
https://www.ncbi.nlm.nih.gov/pubmed/31781369
http://dx.doi.org/10.1155/2019/1424928
work_keys_str_mv AT meishaoyi amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT huangxiaosheng amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT chenglin amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT pengshiming amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT zhutianhui amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT chenliang amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT wangyan amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT zhaojun amissensemutationinopa1causesdominantopticatrophyinachinesefamily
AT meishaoyi missensemutationinopa1causesdominantopticatrophyinachinesefamily
AT huangxiaosheng missensemutationinopa1causesdominantopticatrophyinachinesefamily
AT chenglin missensemutationinopa1causesdominantopticatrophyinachinesefamily
AT pengshiming missensemutationinopa1causesdominantopticatrophyinachinesefamily
AT zhutianhui missensemutationinopa1causesdominantopticatrophyinachinesefamily
AT chenliang missensemutationinopa1causesdominantopticatrophyinachinesefamily
AT wangyan missensemutationinopa1causesdominantopticatrophyinachinesefamily
AT zhaojun missensemutationinopa1causesdominantopticatrophyinachinesefamily